This study is now closed to enrollment. To view currently enrolling studies please go to our currently enrolling studies page. For information on additional studies that will open in the future, please visit our upcoming studies page.
Once Weekly Injection for Type 2 Diabetes
Learn more about lcoSema, a weekly investigational combination injection for people with Type 2 Diabetes.
Enrolling now in West Palm Beach
The COMBINE 2 study is a long-term study comparing the effect and safety of a once-weekly investigational combination product, lcoSema, to that of a once-weekly GLP-1 injection, semaglutide.
*We respect your privacy. All information submitted in this form is transmitted over secure servers, and will be kept strictly confidential and will not be shared without your permission, except as required by law. In response to your inquiry, your information will be added to our in-house database and you will be contacted by email and/or phone by a member of the clinical study team to discuss research opportunities available to you.
Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.
1515 North Flagler Drive • Suite 440 • West Palm Beach, FL 33401 • (561) 802-3060 • email@example.com
© Metabolic Research Institute, Inc. 2016-2022 All Rights Reserved.